Trust Company’s iShares US Medical Devices ETF IHI Stock Holding History

Trust Company’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-906	Closed	-$56.3K	–	909
2025 Q4	$56.3K	Buy	+906	New	+$55.9K	0.01%	276

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Trust Company's IHI Position: Q1 2026 in Review

Trust Company sold out of iShares US Medical Devices ETF (IHI) in Q1 2026, closing a stake of 906 shares — an estimated $56.3K sold.

Trust Company first reported a position in IHI in Q4 2025 and held it in 1 quarter. The position peaked at $56.3K in Q4 2025. 509 funds tracked by Wall St. Rank hold IHI as of Q1 2026.

Trust Company reported no remaining iShares US Medical Devices ETF position as of Q1 2026 after selling out during the quarter.
Trust Company sold 906 iShares US Medical Devices ETF shares in Q1 2026, an estimated $56.3K.
Trust Company first reported a position in iShares US Medical Devices ETF in Q4 2025 and held it in 1 quarter.
Trust Company's iShares US Medical Devices ETF position peaked at $56.3K in Q4 2025.
509 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2026.

Based on Trust Company's 13F filing for Q1 2026, filed 13 Apr 2026.